Do you think that at this point cor has the leverage it needs in negotiating a BP deal? Can this be initiated prior to an IND filing? Might this not be advantageous, since then the company they partner with can play a bigger role in the IND's development? Also, cor would benefit from the BP's experience with the FDA.